Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Perry Shen

Showing results (121-130 of 252) with videos related to

Pageof 26
Sort By:
Journal of Surgical Oncology|June 22, 2021
Persistent opioid use after curative-intent hepatectomy for neoplastic diseaseTracey Pu, Richard A Erali, Michael Share, et al.
Annals of Surgical Oncology|February 6, 2004
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinomaPerry Shen, Jason Hawksworth, James Lovato, et al.
American Journal of Clinical Pathology|January 31, 2004
Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous neviJohn B Holt, Omar P Sangueza, Edward A Levine, et al.
Journal of the American College of Surgeons|January 15, 2018
A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal TumorsEdward A Levine, Konstantinos I Votanopoulos, Perry Shen, et al.
The American Surgeon|April 12, 2013
Optimal timing of systemic therapy in resectable colorectal liver metastasesChukwuemeka Ihemelandu, Edward A Levine, Mebea Aklilu, et al.
Journal of the American College of Surgeons|February 21, 2012
Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomesEdward A Levine, Dan G Blazer, Mickey K Kim, et al.
American Journal of Surgery|October 28, 2022
Effect of preoperative liver-directed therapy prior to hepatic resectionChristopher W Mangieri, Cristian D Valenzuela, Matthew A Strode, et al.
Annals of Surgical Oncology|July 19, 2014
Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Shuja Ahmed, Edward A Levine, Reese W Randle, et al.
Journal of Surgical Oncology|November 29, 2021
Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgeryChristopher W Mangieri, Omeed Moaven, Cristian D Valenzuela, et al.
Annals of Surgical Oncology|January 13, 2022
Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyChristopher W Mangieri, Omeed Moaven, Cristian D Valenzuela, et al.
Pageof 26

Showing results (121-130 of 252) with videos related to

Sort By:
Pageof 26
Journal of Surgical Oncology|June 22, 2021
Persistent opioid use after curative-intent hepatectomy for neoplastic diseaseTracey Pu, Richard A Erali, Michael Share, et al.
Annals of Surgical Oncology|February 6, 2004
Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinomaPerry Shen, Jason Hawksworth, James Lovato, et al.
American Journal of Clinical Pathology|January 31, 2004
Nodal melanocytic nevi in sentinel lymph nodes. Correlation with melanoma-associated cutaneous neviJohn B Holt, Omar P Sangueza, Edward A Levine, et al.
Journal of the American College of Surgeons|January 15, 2018
A Multicenter Randomized Trial to Evaluate Hematologic Toxicities after Hyperthermic Intraperitoneal Chemotherapy with Oxaliplatin or Mitomycin in Patients with Appendiceal TumorsEdward A Levine, Konstantinos I Votanopoulos, Perry Shen, et al.
The American Surgeon|April 12, 2013
Optimal timing of systemic therapy in resectable colorectal liver metastasesChukwuemeka Ihemelandu, Edward A Levine, Mebea Aklilu, et al.
Journal of the American College of Surgeons|February 21, 2012
Gene expression profiling of peritoneal metastases from appendiceal and colon cancer demonstrates unique biologic signatures and predicts patient outcomesEdward A Levine, Dan G Blazer, Mickey K Kim, et al.
American Journal of Surgery|October 28, 2022
Effect of preoperative liver-directed therapy prior to hepatic resectionChristopher W Mangieri, Cristian D Valenzuela, Matthew A Strode, et al.
Annals of Surgical Oncology|July 19, 2014
Significance of diaphragmatic resections and thoracic chemoperfusion on outcomes of peritoneal surface disease treated with cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)Shuja Ahmed, Edward A Levine, Reese W Randle, et al.
Journal of Surgical Oncology|November 29, 2021
Utility of hyperthermic intraperitoneal chemotherapy in cases of incomplete cytoreductive surgeryChristopher W Mangieri, Omeed Moaven, Cristian D Valenzuela, et al.
Annals of Surgical Oncology|January 13, 2022
Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal ChemotherapyChristopher W Mangieri, Omeed Moaven, Cristian D Valenzuela, et al.
Pageof 26